Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel M Verbeek

Showing results (131-140 of 237) with videos related to

Pageof 24
Sort By:
Molecular Neurobiology|November 23, 2018
Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from ControlsTainá M Marques, Anouke van Rumund, Ilona B Bruinsma, et al.
The American Journal of Pathology|December 7, 2007
Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cellsMicha M M Wilhelmus, Irene Otte-Höller, Jos J J van Triel, et al.
Polish Journal of Radiology|August 26, 2016
Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson's Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot StudyFrederick J A Meijer, Stefan C Steens, Anouke van Rumund, et al.
Neurology|June 26, 2026
Incidental DWI-Positive Lesions in 2 Cohorts of CAA and CADASIL: Prevalence, Distribution, and Associations With Clinical VariablesAnnemieke Ter Telgte, Anna M de Kort, Anna Dewenter, et al.
Nucleic Acid Therapeutics|June 1, 2021
Antisense Oligonucleotide-Induced Amyloid Precursor Protein Splicing Modulation as a Therapeutic Approach for Dutch-Type Cerebral Amyloid AngiopathyElena Daoutsali, Tsinatkeab T Hailu, Ronald A M Buijsen, et al.
Journal of Alzheimer'S Disease : JAD|April 23, 2016
Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter StudyMareike Müller, H Bea Kuiperij, Alexandra A M Versleijen, et al.
Molecular & Cellular Proteomics : MCP|June 23, 2005
MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancerLennard J Dekker, Willem Boogerd, Guenther Stockhammer, et al.
Proteins|September 10, 2011
Inhibition of α-synuclein aggregation by small heat shock proteinsIlona B Bruinsma, Kim A Bruggink, Karsten Kinast, et al.
Cellular and Molecular Life Sciences : CMLS|May 20, 2022
The novel P330L pathogenic variant of aromatic amino acid decarboxylase maps on the catalytic flexible loop underlying its crucial roleGiovanni Bisello, Katarzyna Kusmierska, Marcel M Verbeek, et al.
Neurobiology of Aging|September 2, 2011
Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteersDiane Slats, Jurgen A H R Claassen, Petra E Spies, et al.
Pageof 24

Showing results (131-140 of 237) with videos related to

Sort By:
Pageof 24
Molecular Neurobiology|November 23, 2018
Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from ControlsTainá M Marques, Anouke van Rumund, Ilona B Bruinsma, et al.
The American Journal of Pathology|December 7, 2007
Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cellsMicha M M Wilhelmus, Irene Otte-Höller, Jos J J van Triel, et al.
Polish Journal of Radiology|August 26, 2016
Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson's Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot StudyFrederick J A Meijer, Stefan C Steens, Anouke van Rumund, et al.
Neurology|June 26, 2026
Incidental DWI-Positive Lesions in 2 Cohorts of CAA and CADASIL: Prevalence, Distribution, and Associations With Clinical VariablesAnnemieke Ter Telgte, Anna M de Kort, Anna Dewenter, et al.
Nucleic Acid Therapeutics|June 1, 2021
Antisense Oligonucleotide-Induced Amyloid Precursor Protein Splicing Modulation as a Therapeutic Approach for Dutch-Type Cerebral Amyloid AngiopathyElena Daoutsali, Tsinatkeab T Hailu, Ronald A M Buijsen, et al.
Journal of Alzheimer'S Disease : JAD|April 23, 2016
Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter StudyMareike Müller, H Bea Kuiperij, Alexandra A M Versleijen, et al.
Molecular & Cellular Proteomics : MCP|June 23, 2005
MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancerLennard J Dekker, Willem Boogerd, Guenther Stockhammer, et al.
Proteins|September 10, 2011
Inhibition of α-synuclein aggregation by small heat shock proteinsIlona B Bruinsma, Kim A Bruggink, Karsten Kinast, et al.
Cellular and Molecular Life Sciences : CMLS|May 20, 2022
The novel P330L pathogenic variant of aromatic amino acid decarboxylase maps on the catalytic flexible loop underlying its crucial roleGiovanni Bisello, Katarzyna Kusmierska, Marcel M Verbeek, et al.
Neurobiology of Aging|September 2, 2011
Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteersDiane Slats, Jurgen A H R Claassen, Petra E Spies, et al.
Pageof 24